19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha) | Health Canada | Drug Product Database | DPD | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha)
Canada

PharmaCompass Sponsored Ads

Contact Supplier

Gonane Norethisterone acetate

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

19-Norpregn-4-en-20-yn-3-one, 17-(acetyloxy)-, (17alpha)

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

21 API Suppliers, 12 USDMF, 4 CEP/COS, 2 JDMF, 3 EU WC, 6 NDC API, 11 Listed Suppliers, $ API Reference Price

21 API Suppliers
12 USDMF
4 CEP/COS
2 JDMF
3 EU WC
6 NDC API
11 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

25 Drugs in Development

25 Drugs in Development

FINISHED DOSAGE FORMULATIONS

171 FDF Dossiers, 119 FDA Orange Book, 39 Europe, 7 Canada, 6 Listed Dossiers

171 FDF Dossiers
119 FDA Orange Book
39 Europe
7 Canada
6 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL-28 - 0.02MG;1MG, TABLET;ORAL-21 - 0.03MG;1.5MG, TABLET;ORAL-21 - 0.03MG;1.5MG, TABLET;ORAL-21 - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL-21 - 0.02MG,0.03MG,0.035MG;1MG,1MG,1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE, TABLET;INTRAMUSCULAR, ORAL - 11.25MG/VIAL,N/A;N/A,5MG, INJECTABLE, TABLET;INTRAMUSCULAR, ORAL - 3.75MG/VIAL,N/A;N/A,5MG, CAPSULE;ORAL - 0.02MG;1MG, TABLET, CHEWABLE, TABLET;ORAL - 0.01MG,0.01MG,N/A;1MG,N/A,N/A, FILM, EXTENDED RELEASE;TRANSDERMAL - 0.05MG/24HR;0.14MG/24HR, FILM, EXTENDED RELEASE;TRANSDERMAL - 0.05MG/24HR;0.25MG/24HR, TABLET;ORAL - 0.5MG;0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 1MG;0.5MG, TABLET;ORAL - 0.0025MG;0.5MG, TABLET;ORAL - 0.005MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 0.01MG,0.01MG;1MG,N/A

TABLET;ORAL-28 - 0.02MG;1MG
TABLET;ORAL-21 - 0.03MG;1.5MG
TABLET;ORAL-21 - 0.03MG;1.5MG
TABLET;ORAL-21 - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL-21 - 0.02MG,0.03MG,0.035MG;1MG,1MG,1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE, TABLET;INTRAMUSCULAR, ORAL - 11.25MG/VIAL,N/A;N/A,5MG
INJECTABLE, TABLET;INTRAMUSCULAR, ORAL - 3.75MG/VIAL,N/A;N/A,5MG
CAPSULE;ORAL - 0.02MG;1MG
TABLET, CHEWABLE, TABLET;ORAL - 0.01MG,0.01MG,N/A;1MG,N/A,N/A
FILM, EXTENDED RELEASE;TRANSDERMAL - 0.05MG/24HR;0.14MG/24HR
FILM, EXTENDED RELEASE;TRANSDERMAL - 0.05MG/24HR;0.25MG/24HR
TABLET;ORAL - 0.5MG;0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 1MG;0.5MG
TABLET;ORAL - 0.0025MG;0.5MG
TABLET;ORAL - 0.005MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 0.01MG,0.01MG;1MG,N/A

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc, 5 SPI Pharma, 4 DKSH, 2 Jai Radhe Sales, 7 Faran Shimi Pharmaceutical, 6 Boai NKY Pharmaceuticals Ltd, 13 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 4 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 19 BASF, 2 Clariant, 11 Corel Pharma Chem, 7 DFE Pharma, 1 Doshion Polyscience, 11 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 7 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 38 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 1 Nanjing Bold Chemical, 4 Novo Excipients, 3 Pharmatrans-Sanaq, 7 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 23 Roquette, 13 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 12 Sigachi Industries, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 5 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

86 Fillers, Diluents & Binders, 56 Coating Systems & Additives, 41 Direct Compression, 34 Disintegrants & Superdisintegrants, 29 Controlled & Modified Release, 27 Granulation, 26 Solubilizers, 23 Thickeners and Stabilizers, 21 Lubricants & Glidants, 19 Co-Processed Excipients, 17 Taste Masking, 16 Film Formers & Plasticizers, 14 Parenteral, 10 Emulsifying Agents, 9 Topical, 8 API Stability Enhancers, 7 Chewable & Orodispersible Aids, 6 Rheology Modifiers, 5 Empty Capsules, 5 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules

86 Fillers, Diluents & Binders
56 Coating Systems & Additives
41 Direct Compression
34 Disintegrants & Superdisintegrants
29 Controlled & Modified Release
27 Granulation
26 Solubilizers
23 Thickeners and Stabilizers
21 Lubricants & Glidants
19 Co-Processed Excipients
17 Taste Masking
16 Film Formers & Plasticizers
14 Parenteral
10 Emulsifying Agents
9 Topical
8 API Stability Enhancers
7 Chewable & Orodispersible Aids
6 Rheology Modifiers
5 Empty Capsules
5 Surfactant & Foaming Agents
5 Coloring Agents
4 Vegetarian Capsules

DIGITAL CONTENT

3 DATA COMPILATION #PharmaFlow, 47 NEWS #PharmaBuzz

3 DATA COMPILATION #PharmaFlow
47 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 40 Finished Drug Prices, 9 Annual Reports

2 US Medicaid Prescriptions
40 Finished Drug Prices
9 Annual Reports

MARKET PLACE

7 APIs

7 APIs

PATENTS & EXCLUSIVITIES

9 US Patents, 5 US Exclusivities

9 US Patents
5 US Exclusivities

REF. STANDARDS & IMPURITIES

2 EDQM, 1 USP, 3 Others

2 EDQM
1 USP
3 Others

$ API Ref.Price (USD/KG) : 7,469 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

7 All

01 1ABBVIE CORPORATION

02 2NOVO NORDISK CANADA INC

03 2SANDOZ CANADA INCORPORATED

04 1SEARCHLIGHT PHARMA INC

05 1SUMITOMO PHARMA SWITZERLAND GMBH

filter Active Ingredients Reset all filters

7 All

01 7NORETHINDRONE ACETATE

filter Dosage Form Reset all filters

7 All

01 2PATCH

02 5TABLET

filter Brand Name Reset all filters

7 All

01 1ACTIVELLE

02 1ACTIVELLE LD

03 1ESTALIS 140/50 MCG

04 1ESTALIS 250/50 MCG

05 1LOLO

06 1MYFEMBREE

07 1NORLUTATE

Coral Drugs Norethisterone Acetate

List of Suppliers

Product Main Page

01

ABBVIE CORPORATION

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Contact Supplier

Contact Supplier

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

NORETHINDRONE ACETATE

Brand Name : LOLO

Dosage Form : TABLET

Dosage Strength : 1MG

Packaging :

Approval Date :

Application Number : 2417456

Regulatory Info : Prescription

Registration Country : Canada

Abbvie Company Banner

Product Web Link

Digital Content

Corporate PDF

02

NOVO NORDISK CANADA INC

Pharmtech & Ingredients

Not Confirmed

NOVO NORDISK CANADA INC

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

NORETHINDRONE ACETATE

Brand Name : ACTIVELLE

Dosage Form : TABLET

Dosage Strength : 0.5MG

Packaging : 28

Approval Date :

Application Number : 2249405

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

NOVO NORDISK CANADA INC

Pharmtech & Ingredients

Not Confirmed

NOVO NORDISK CANADA INC

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

NORETHINDRONE ACETATE

Brand Name : ACTIVELLE LD

Dosage Form : TABLET

Dosage Strength : 0.1MG

Packaging : 28

Approval Date :

Application Number : 2309009

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

SANDOZ CANADA INCORPORATED

Pharmtech & Ingredients

Not Confirmed

SANDOZ CANADA INCORPORATED

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

NORETHINDRONE ACETATE

Brand Name : ESTALIS 250/50 MCG

Dosage Form : PATCH

Dosage Strength : 250MCG/24HOUR

Packaging : 8

Approval Date :

Application Number : 2241837

Regulatory Info : Prescription

Registration Country : Canada

Product Web Link

Digital Content

05

SANDOZ CANADA INCORPORATED

Pharmtech & Ingredients

Not Confirmed

SANDOZ CANADA INCORPORATED

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

NORETHINDRONE ACETATE

Brand Name : ESTALIS 140/50 MCG

Dosage Form : PATCH

Dosage Strength : 140MCG/24HOUR

Packaging : 8

Approval Date :

Application Number : 2241835

Regulatory Info : Prescription

Registration Country : Canada

Product Web Link

Digital Content

06

SEARCHLIGHT PHARMA INC

Pharmtech & Ingredients

Not Confirmed

SEARCHLIGHT PHARMA INC

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

NORETHINDRONE ACETATE

Brand Name : NORLUTATE

Dosage Form : TABLET

Dosage Strength : 5MG

Packaging : 30

Approval Date :

Application Number : 23760

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

07

SUMITOMO PHARMA SWITZERLAND GMBH

Country

Pharmtech & Ingredients

Not Confirmed

SUMITOMO PHARMA SWITZERLAND GMBH

Country

Pharmtech & Ingredients

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Country

Virtual Booth

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

NORETHINDRONE ACETATE

Brand Name : MYFEMBREE

Dosage Form : TABLET

Dosage Strength : 0.5MG

Packaging :

Approval Date :

Application Number : 2541742

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?